Curated News
By: NewsRamp Editorial Staff
October 09, 2024

Premier TMS of LA Announces Availability of Neuronetics' TMS Technology for Adolescent Major Depressive Disorder

Reddit Discuss on RedditDiscuss on Substack SubstackDiscuss on Telegram TelegramView History of this news story on GitHub Github
Source News Release

TLDR

  • Premier TMS of LA gains advantage by offering Neuronetics' FDA-cleared TMS technology for adolescent major depressive disorder treatment.
  • The FDA cleared Neuronetics' TMS device for adolescents aged 15 to 21, offering non-invasive treatment for major depressive disorder.
  • This development provides hope for adolescents struggling with depression, expanding treatment options and emphasizing personalized care for each patient.
  • Neuronetics' innovative TMS technology offers a non-invasive and targeted approach to treating adolescent major depressive disorder.

Impact - Why it Matters

The availability of Neuronetics' TMS technology for adolescent major depressive disorder represents a crucial milestone in mental health treatment. This clearance not only broadens the treatment landscape for adolescent depression but also underscores our commitment to providing innovative and effective mental health solutions.

Summary

Premier TMS of LA, a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, is now offering Neuronetics' innovative TMS technology for the treatment of adolescent major depressive disorder (MDD) following FDA clearance. Dr. John Deirmenjian, CEO of Premier TMS of LA, expressed enthusiasm about the potential impact of this development on patient care. With this latest clearance, Neuronetics expands the reach of TMS therapy to adolescents, offering hope to those who may have previously faced limited treatment options. Premier TMS of LA continues to lead the way in advancing mental health care through cutting-edge treatments such as TMS therapy.

Source Statement

This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, Premier TMS of LA Announces Availability of Neuronetics' TMS Technology for Adolescent Major Depressive Disorder

blockchain registration record for the source press release.